Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

262 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Reply to Scalone and Cortesi: "Cost-utility analysis of biologic therapies to treat chronic plaque psoriasis in Italy: the importance of using updated and adequate social tariffs to calculate QALYs".
Spandonaro F, Ayala F, Berardesca E, Chimenti S, Girolomoni G, Martini P, Peserico A, Polistena B, Guerra AP, Vena GA, Altomare G, Pinton PC. Spandonaro F, et al. Among authors: vena ga. BioDrugs. 2015 Feb;29(1):71-2. doi: 10.1007/s40259-015-0118-5. BioDrugs. 2015. PMID: 25647521 Free article. No abstract available.
Etanercept provides a more physiological approach in the treatment of psoriasis.
Altomare G, Ayala F, Berardesca E, Chimenti S, Giannetti A, Girolomoni G, Lotti T, Martini P, Peserico A, Guerra AP, Vena GA. Altomare G, et al. Among authors: vena ga. Dermatol Ther. 2008 Oct;21 Suppl 2:S1-14. doi: 10.1111/j.1529-8019.2008.00226.x. Dermatol Ther. 2008. PMID: 18837727 Review.
Cost-effectiveness analysis of TNF-alpha blockers for the treatment of chronic plaque psoriasis in the perspective of the Italian health-care system.
de Portu S, Del Giglio M, Altomare G, Arcangeli F, Berardesca E, Calzavara-Pinton P, Lotti T, Martini P, Peserico A, Simonacci M, Vena GA, Girolomoni G. de Portu S, et al. Among authors: vena ga. Dermatol Ther. 2010 Jan-Feb;23 Suppl 1:S7-13. doi: 10.1111/j.1529-8019.2009.01280.x. Dermatol Ther. 2010. PMID: 20136921
Differential management of mild-to-severe psoriasis with biologic drugs: An Italian Delphi consensus expert panel.
Girolomoni G, Altomare G, Ayala F, Berardesca E, Calzavara Pinton P, Chimenti S, Martini P, Peserico A, Puglisi Guerra A, Vena GA; Delphi working group. Girolomoni G, et al. Among authors: vena ga. J Dermatolog Treat. 2015 Apr;26(2):128-33. doi: 10.3109/09546634.2014.907466. Epub 2014 Apr 8. J Dermatolog Treat. 2015. PMID: 24708158 Free article.
Incidence of psoriasis and association with comorbidities in Italy: a 5-year observational study from a national primary care database.
Vena GA, Altomare G, Ayala F, Berardesca E, Calzavara-Pinton P, Chimenti S, Giannetti A, Girolomoni G, Lotti T, Martini P, Mazzaglia G, Peserico A, Puglisi Guerra A, Sini G, Cassano N, Cricelli C. Vena GA, et al. Eur J Dermatol. 2010 Sep-Oct;20(5):593-8. doi: 10.1684/ejd.2010.1017. Epub 2010 Jul 7. Eur J Dermatol. 2010. PMID: 20605768
The GENDER ATTENTION Observational Study: Gender and Hormonal Status Differences in the Incidence of Adverse Events During Cyclosporine Treatment in Psoriatic Patients.
Colombo D, Banfi G, Cassano N, Graziottin A, Vena GA, Fiori GG, Zagni E, Stingeni L, Chimenti S, Berardesca E, Micali G, Albertini G, De Simone C, Bellia G; GENDER ATTENTION study group. Colombo D, et al. Among authors: vena ga. Adv Ther. 2017 Jun;34(6):1349-1363. doi: 10.1007/s12325-017-0526-7. Epub 2017 Apr 21. Adv Ther. 2017. PMID: 28432647 Free PMC article.
262 results